Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study).
Aho S, Osterlund E, Ristimäki A, Nieminen L, Sundström J, Mäkinen MJ, Kuopio T, Kytölä S, Ålgars A, Ristamäki R, Heervä E, Kallio R, Halonen P, Soveri LM, Nordin A, Uutela A, Salminen T, Stedt H, Lamminmäki A, Muhonen T, Kononen J, Glimelius B, Isoniemi H, Lehto JT, Lehtomäki K, Osterlund P. Aho S, et al. Among authors: makinen mj. Cancers (Basel). 2024 Mar 5;16(5):1052. doi: 10.3390/cancers16051052. Cancers (Basel). 2024. PMID: 38473410 Free PMC article.
Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study.
Uutela A, Osterlund E, Halonen P, Kallio R, Ålgars A, Salminen T, Lamminmäki A, Soveri LM, Ristamäki R, Lehtomäki K, Stedt H, Heervä E, Muhonen T, Kononen J, Nordin A, Ovissi A, Kytölä S, Keinänen M, Sundström J, Nieminen L, Mäkinen MJ, Kuopio T, Ristimäki A, Isoniemi H, Osterlund P. Uutela A, et al. Among authors: makinen mj. Br J Cancer. 2022 Sep;127(4):686-694. doi: 10.1038/s41416-022-01858-8. Epub 2022 May 24. Br J Cancer. 2022. PMID: 35610367 Free PMC article. Clinical Trial.
Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial).
Uutela A, Ovissi A, Hakkarainen A, Ristimäki A, Lundbom N, Kallio R, Soveri LM, Salminen T, Ålgars A, Halonen P, Ristamäki R, Nordin A, Blanco Sequeiros R, Rinta-Kiikka I, Lantto E, Virtanen J, Pääkkö E, Liukkonen E, Saunavaara J, Ryymin P, Lammentausta E, Osterlund P, Isoniemi H; RAXO Study Group. Uutela A, et al. ESMO Open. 2021 Aug;6(4):100208. doi: 10.1016/j.esmoop.2021.100208. Epub 2021 Jul 26. ESMO Open. 2021. PMID: 34325107 Free PMC article.
KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer.
Osterlund E, Ristimäki A, Kytölä S, Kuopio T, Heervä E, Muhonen T, Halonen P, Kallio R, Soveri LM, Sundström J, Keinänen M, Ålgars A, Ristamäki R, Sorbye H, Pfeiffer P, Nunes L, Salminen T, Lamminmäki A, Mäkinen MJ, Sjöblom T, Isoniemi H, Glimelius B, Osterlund P. Osterlund E, et al. Among authors: makinen mj. Front Oncol. 2022 Feb 16;12:826073. doi: 10.3389/fonc.2022.826073. eCollection 2022. Front Oncol. 2022. PMID: 35251991 Free PMC article.
Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
Uutela A, Nordin A, Osterlund E, Halonen P, Kallio R, Soveri LM, Salminen T, Ålgars A, Ristimäki A, Ovissi A, Lamminmäki A, Muhonen T, Kononen J, Ristamäki R, Heervä E, Stedt H, Lehtomäki K, Kytölä S, Sundström J, Mäkinen MJ, Nieminen L, Kuopio T, Keinänen M, Osterlund P, Isoniemi H; RAXO Study Group. Uutela A, et al. Among authors: makinen mj. Br J Surg. 2023 Jul 17;110(8):931-935. doi: 10.1093/bjs/znac424. Br J Surg. 2023. PMID: 36511370 Free PMC article. No abstract available.
Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts.
Osterlund E, Ristimäki A, Mäkinen MJ, Kytölä S, Kononen J, Pfeiffer P, Soveri LM, Keinänen M, Sorbye H, Nunes L, Salminen T, Nieminen L, Uutela A, Halonen P, Ålgars A, Sundström J, Kallio R, Ristamäki R, Lamminmäki A, Stedt H, Heervä E, Kuopio T, Sjöblom T, Isoniemi H, Glimelius B, Osterlund P. Osterlund E, et al. Among authors: makinen mj. Int J Cancer. 2024 Feb 1;154(3):488-503. doi: 10.1002/ijc.34733. Epub 2023 Sep 19. Int J Cancer. 2024. PMID: 37724848
Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer.
Elomaa H, Ahtiainen M, Väyrynen SA, Ogino S, Nowak JA, Friman M, Helminen O, Wirta EV, Seppälä TT, Böhm J, Mäkinen MJ, Mecklin JP, Kuopio T, Väyrynen JP. Elomaa H, et al. Among authors: makinen mj. Br J Cancer. 2022 Aug;127(3):514-523. doi: 10.1038/s41416-022-01822-6. Epub 2022 Apr 21. Br J Cancer. 2022. PMID: 35449453 Free PMC article.
Immunohistochemical somatostatin receptor expression in insulinomas.
Peltola E, Vesterinen T, Leijon H, Hannula P, Huhtala H, Mäkinen M, Nieminen L, Pirinen E, Rönty M, Söderström M, Arola J, Jaatinen P. Peltola E, et al. APMIS. 2023 Apr;131(4):152-160. doi: 10.1111/apm.13297. Epub 2023 Feb 7. APMIS. 2023. PMID: 36680557
Immunological and prognostic significance of tumour necrosis in colorectal cancer.
Kastinen M, Sirniö P, Elomaa H, Ahtiainen M, Väyrynen SA, Herzig KH, Meriläinen S, Aro R, Häivälä R, Rautio T, Saarnio J, Wirta EV, Helminen O, Seppälä TT, Kuopio T, Böhm J, Tuomisto A, Mecklin JP, Mäkinen MJ, Väyrynen JP. Kastinen M, et al. Among authors: makinen mj. Br J Cancer. 2023 Jun;128(12):2218-2226. doi: 10.1038/s41416-023-02258-2. Epub 2023 Apr 8. Br J Cancer. 2023. PMID: 37031328 Free PMC article.
114 results